Those who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks set to return ...

AbbVie is grappling with diminishing Humira sales and is also trading at an above-average P/E. See why I rate ABBV stock as a ...

The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due to the better-than-expected fourth-quarter performance of large ...

Market sentiment charts show selling pressure subsiding, but panic could trigger a bullish turn. The stock market's constant reaction to policy uncertainty and tariffs has dominated the news over ...

The data show exactly that. Before the earth-shaking numbers that Keytruda put up, AbbVie’s arthritis drug Humira was the reigning champ. After gaining approval in 2008, AbbVie racked up indications ...

It also makes the Hot Rock & Alternative Songs chart at No. 9 with 5.1 million U.S. streams (up 17%). Still in rotation at multiple radio formats, it additionally logged 3.9 million in airplay ...

HYDERABAD, India - Dr. Reddy’s Laboratories Ltd. and Alvotech announced that the U.S. Food and Drug Administration (FDA ... highlighting potential positive developments with biosimilar Humira and ...

In the American drug industry, a trend has developed among manufacturers and pharmacy benefits managers (PBM) that threatens to upend a productive balance between rewarding manufacturer innovation ...

The Health Secretary has said there is an “overdiagnosis” of mental health conditions with “too many people being written off” as he defended plans to cut the benefits bill. Wes Streeting ...

The prescribed dosage for dexamethasone may depend on a person’s treatment plan. Other factors, including your specific diagnosis, body weight, and medical history, may affect your dosage of ...